MEI Pharma (NASDAQ:MEIP) Receives New Coverage from Analysts at StockNews.com
StockNews.com began coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a research note issued to investors on Friday. The firm issued a buy rating on the stock. Several other equities analysts have also recently issued reports on MEIP. Laidlaw cut shares of MEI Pharma from a buy rating to a hold rating […]
24 Sep 01:33 · The Cerbat Gem